Embecta Corp
Ownership
Ownership Structure
Who owns Embecta Corp (EMBC)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 96.7% of the shares are freely tradable; institutional investors hold 90.6%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 8.12 | 4,599,771 | -49.8 | 06/30/2026 |
| Yacktman Asset Management Co | 7.62 | 4,315,952 | +17.5 | 06/30/2026 |
| Vanguard Capital Management, LLC | 4.51 | 2,557,148 | -0.3 | 06/30/2026 |
| Deerfield Management Co | 4.47 | 2,534,961 | +0.0 | 06/30/2026 |
| Jefferies Financial Group Inc | 4.16 | 2,355,117 | +0.0 | 06/30/2026 |
| Ameriprise Financial Inc | 3.60 | 2,038,731 | +154.9 | 06/30/2026 |
| Morgan Stanley - Brokerage Accounts | 3.52 | 1,996,747 | +227.4 | 06/30/2026 |
| State Street Corp | 2.84 | 1,610,666 | -36.7 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| AMG Yacktman I | 6.18 | 3,500,000 | +0.0 | 09/30/2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 3.23 | 1,831,834 | +0.0 | 09/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Kurdikar Devdatt | President and CEO | 804,919 | 5,231,972 $ | Aug 12, 2026 | direct |
| Elguicze Jacob | SVP and CFO | 309,139 | 2,009,401 $ | Aug 12, 2026 | direct |
| Mann Jeffrey Z | Pres, Pharm Svc&Prod Mgmt, CLO | 262,915 | 1,708,948 $ | Aug 12, 2026 | direct |
| Hombach Robert J. | Director | 109,587 | 712,317 $ | Aug 12, 2026 | direct |
| Morris Milton Mayo | Director | 53,828 | 349,884 $ | Sep 4, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 4, 2026 | Morris Milton Mayo | Director | Sell | 6,293 | 5.88 | 36,971 |
| Aug 12, 2026 | Kurdikar Devdatt | President and CEO | Buy | 30,000 | 4.70 | 140,937 |
| Aug 12, 2026 | Elguicze Jacob | SVP and CFO | Buy | 20,000 | 4.67 | 93,360 |
| Aug 12, 2026 | Mann Jeffrey Z | Pres, Pharm Svc&Prod Mgmt, CLO | Buy | 20,000 | 4.99 | 99,800 |
| Aug 12, 2026 | Hombach Robert J. | Director | Buy | 45,000 | 4.97 | 223,848 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: November 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.